Using OCT to predict neurodevelopmental risk in preterm infants: Cynthia Toth, MDByCytnthia Toth, MD,Lucia Gambuzza,Abigail Lewis, Content InternJuly 8th 2026
Revakinagene taroretcel-lwey for MacTel: Charles Wykoff, MD, PhD, on a year of real-world experienceByCharles C. Wykoff, MD, PhD,Lucia GambuzzaJuly 2nd 2026
The Wills Retina Report: Regillo and Garg on managing geographic atrophy—who, when, and howByCarl D. Regillo, MD, FACS, FASRS,Sunir J. Garg, MD, FACS, FASRSJune 26th 2026
Eichenbaum Acorns: From clinic to C-suite with Jay S. Duker, MD, and Ramiro Ribeiro, MD, PhDByDavid A. Eichenbaum, MD, FASRS,Jay S. Duker, MD ,Ramiro Ribeiro, MD, PhDJune 19th 2026
CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practiceByMark R. Barakat, MD,Lucia GambuzzaJune 15th 2026